Among the 21,747 consecutive treatment-naïve patients diagnosed with various stages of lung cancer who submitted samples for ROS1 detection, 447 were positive for ROS1 rearrangements, revealing an overall prevalence rate of 2.1%. This evidence concerns the gene ROS1 and lung carcinoma.